Skip to main content

Aldeyra Therapeutics, Inc.

ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001341235

In the last 90 days, Aldeyra Therapeutics, Inc. insiders filed 3 open-market purchases and 0 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Aldeyra Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
3 filings
3 insiders, $140.3K in total
Open-market sells
0 filings
Insiders trading
3
Net value
+$140.3K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Aldeyra Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Aldeyra Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Deptula-Hicks Darlene MDirector7,500Nov 16, 20262
Alfieri MichaelPrincipal Financial Officer17,500Nov 13, 20262
Douglas RichardDirector395,000Nov 13, 20263
Phillips Gary M.Director14,812Jun 11, 20261
Clark William DDirector–Jun 11, 20261
Walker NealDirector15,854Jun 11, 20261
Bronstein BenDirector28,248Jun 11, 20261
Miller-Rich NancyDirector922Jun 11, 20261
Brady Todd CPresident and CEO1,721,298Jun 5, 20262
Machatha StephenChief Development Officer221,799Aug 13, 20250
Joyce Martin JosephDirector23,967Jun 12, 20250
Edelman Joseph10% Owner5,875,851IndirectApr 7, 20250
Perceptive Advisors LLC10% Owner5,875,851IndirectApr 7, 20250
Perceptive Life Sciences Master Fund Ltd10% Owner5,875,851IndirectApr 7, 20250
Greenberg BruceSee Remarks126,382Aug 14, 20240
Reed JoshuaChief Financial Officer274,825Apr 1, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2026 (view filing)5:33 PM ETNov 124 daysDeptula-Hicks Darlene MDirectorPPurchase+7.50K$0.65+$4.88KNew position7.50K after
Nov 13, 2026 (view filing)4:31 PM ETNov 112 daysAlfieri MichaelPrincipal Financial OfficerPPurchase+10.0K$0.65+$6.50K+133.3%17.5K after
Nov 13, 2026 (view filing)4:26 PM ETNov 112 daysDouglas RichardDirectorPPurchase+200.0K$0.6445+$128.9K+102.6%395.0K after
Jun 5, 2026 (view filing)Jun 32 daysBrady Todd CPresident and CEOPPurchase+250.0K$1.67+$417.5K+17.0%1.72M after
Mar 20, 2026 (view filing)Mar 191 dayDouglas RichardDirectorPPurchase+70.0K$1.40+$98.0K+56.0%195.0K after
Mar 19, 2026 (view filing)Mar 181 dayAlfieri MichaelPrincipal Financial OfficerPPurchase+5.00K$1.42+$7.10K+200.0%7.50K after
Aug 15, 2025 (view filing)Aug 132 daysAlfieri MichaelPrincipal Financial OfficerPPurchase+2.50K$5.30+$13.3KNew position2.50K after
Aug 13, 2025 (view filing)Aug 112 daysMachatha StephenChief Development OfficerSSale−22.1K$5.15−$113.7K−9.1%221.8K after
Apr 7, 2025 (view filing)6:43 PM ETApr 34 daysEdelman Joseph and 2 others10% OwnerSSale−3.40M$1.42−$4.83M−36.7%5.88M after
Oct 21, 2024 (view filing)May 3, 2021-Apr 12, 20231,267 daysLateMiller-Rich NancyDirectorPPurchase+922$11.33+$10.4KNew position922 after2 lots
Aug 14, 2024 (view filing)Aug 122 daysMachatha StephenChief Development OfficerSSale−16.0K$4.74−$76.0K−6.3%236.8K after
Aug 14, 2024 (view filing)Aug 122 daysGreenberg BruceSee RemarksSSale−10.8K$4.74−$51.4K−7.9%126.4K after
Apr 17, 2024 (view filing)Mar 1236 daysMachatha StephenChief Development OfficerSSale−11.5K$3.16−$36.5K−4.4%252.8K afterAmended
Apr 17, 2024 (view filing)Mar 1137 daysGreenberg BruceSee RemarksSSale−13.2K$3.41−$45.0K−9.2%130.2K afterAmended
Apr 8, 2024 (view filing)5:32 PM ETApr 4-54 daysEdelman Joseph and 2 others10% OwnerPPurchase+178.0K$4.68+$833.9K+2.0%9.28M after2 lots
Apr 3, 2024 (view filing)5:22 PM ETApr 1-32 daysEdelman Joseph and 2 others10% OwnerPPurchase+504.3K$3.84+$1.93M+5.9%9.10M after3 lots
Mar 12, 2024 (view filing)Mar 111 dayMachatha StephenChief Development OfficerSSale−18.2K$3.41−$62.2K−6.7%255.0K afterFrom original
Mar 12, 2024 (view filing)Mar 11-121 dayBrady Todd CPresident and CEOSSale−183.2K$3.17−$580.4K−11.1%1.47M after2 lots
Oct 18, 2023 (view filing)5:15 PM ETOct 16-182 daysEdelman Joseph and 2 others10% OwnerSSale−2.76M$1.62−$4.45M−24.3%8.59M after2 lots
Aug 11, 2022 (view filing)4:08 PM ETAug 9-102 daysEdelman Joseph and 2 others10% OwnerPPurchase+115.0K$7.55+$867.8K+1.0%11.4M after2 lots
Aug 10, 2022 (view filing)4:10 PM ETAug 82 daysEdelman Joseph and 2 others10% OwnerPPurchase+97.0K$7.24+$702.3K+0.9%11.2M after
Aug 9, 2022 (view filing)4:08 PM ETAug 54 daysEdelman Joseph and 2 others10% OwnerPPurchase+141.0K$6.95+$980.0K+1.3%11.1M after
Aug 8, 2022 (view filing)4:09 PM ETAug 44 daysEdelman Joseph and 2 others10% OwnerPPurchase+95.1K$6.17+$586.8K+0.9%11.0M after
Aug 5, 2022 (view filing)4:10 PM ETAug 32 daysEdelman Joseph and 2 others10% OwnerPPurchase+100.0K$5.84+$584.0K+0.9%10.9M after
Aug 4, 2022 (view filing)4:10 PM ETAug 22 daysEdelman Joseph and 2 others10% OwnerPPurchase+412.4K$5.59+$2.31M+4.0%10.8M after
Aug 3, 2022 (view filing)5:16 PM ETAug 12 daysEdelman Joseph and 2 others10% OwnerPPurchase+144.2K$5.05+$728.1K+1.4%10.4M after
Aug 2, 2022 (view filing)4:27 PM ETJul 294 daysEdelman Joseph and 2 others10% OwnerPPurchase+222.1K$5.03+$1.12M+2.2%10.2M after
Aug 1, 2022 (view filing)5:37 PM ETJul 284 daysEdelman Joseph and 2 others10% OwnerPPurchase+119.4K$5.00+$597.0K+1.2%10.0M after
Jun 27, 2022 (view filing)Jun 234 daysJoyce Martin JosephDirectorPPurchase+4.32K$3.48+$15.0K+22.0%24.0K after
Jun 27, 2022 (view filing)Jun 234 daysBrady Todd CPresident and CEOPPurchase+17.7K$3.36+$59.5K+1.5%1.22M after